SOURCE: Kantar Health

Kantar Health

March 22, 2011 05:05 ET

Kantar Health Names Andrew Miniuks Senior Director, Oncology Market Access

NEW YORK, NY--(Marketwire - March 22, 2011) - Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Andrew Miniuks Senior Director, Oncology Market Access Europe. In this role he will lead the development and advancement of Kantar Health's Oncology Market Access Europe publication, support Kantar Health's growing global oncology practice, and lead and support custom consulting engagements in oncology.

Mr. Miniuks most recently was a Program Director with the National Institute for Health and Clinical Excellence (NICE) supporting the development of NHS Evidence, a new web-based search engine and information portal for healthcare professionals within the UK National Health Service who want to understand best practice. At Pfizer UK Mr. Miniuks was a Strategic Development Manager tracking policy developments in the UK and their impact on commercial operations. He was a management consultant in the Pharmaceuticals and Healthcare Practice at AT Kearney, focusing on pricing and reimbursement and payer relations.

"Andrew joins Kantar Health with highly relevant experience in the private and public sectors and as a consultant to the pharma industry," says Patricia Ensor, R.Ph., Senior Vice President in Kantar Health's Commercial Development practice. "His background adds to Kantar Health's global oncology offer, which combines multiclient materials and custom consulting by domain experts. This integrated approach and our depth of oncology expertise truly set us apart from the competition."

Mr. Miniuks holds a BA in Chemistry and a BS in Geology from the University of Massachusetts; an MA in Geochemistry from Boston University; and an MBA from the London Business School.

About Oncology Market Access Europe
Oncology Market Access Europe, published annually, provides information and insight that helps market access, pricing and reimbursement, and marketing and sales professionals successfully operate in the increasingly scrutinized and regulated oncology marketplace in the EU Big 5, i.e., France, Germany, Italy, Spain and the United Kingdom. Country-specific data, cross-country analyses and interactive presentations are supported by detailed research and analysis of the oncology commercial environment utilizing internal and external thought leaders. For more information on this publication, please email the Oncology Market Access team.

About Kantar Health (
As experts in pharmaceutical and biotechnology consulting and market research, Kantar Health offers unique insights and products that deliver proven results for marketing insights, brand marketing, business development and health economics and outcomes professionals, including:

  • The greatest breadth and depth of epidemiology information in the world, spanning patient-reported outcomes and patient care by country, therapy area, specialist -- or whatever combination of data you require
  • Unmatched experience in the complex oncology market that encompasses business development, clinical management, emerging technologies, marketing and sales, payers and providers, reimbursement and strategic and product planning
  • A unique global source of KOLs for multiple therapy areas

Kantar Health's team combines doctorate-level scientific expertise with strong business know-how, ensuring that solutions are both evidence-based and commercially focused. By uniting industry leaders MattsonJack, TNS Healthcare, Consumer Health Sciences and Ziment, we offer a wide range of expertise in emerging as well as established markets, spanning the product life cycle from product portfolio management to licensing, market access to brand and reputation management, detailing to clinical research, patient outcomes and sales force effectiveness to health and safety. And as part of WPP, the largest marketing agency in the world, Kantar Health can leverage the power of the global group with shared offline and online research methodologies but remain culturally specific and nimble. Kantar Health focuses on getting you the best return.

Contact Information

  • Contact Information
    For more information on Kantar Health, please contact
    Paula Paradise
    Vice President of Global Marketing
    Email Contact